Revenue for ultrasound imaging manufacturer EndoSonics was $48.2 million at the end of 1999, up from $44.1 million in 1998. Revenue for the fourth quarter, however, was only $11.7 million, compared with $13.3 million for the fourth quarter of the
Revenue for ultrasound imaging manufacturer EndoSonics was $48.2 million at the end of 1999, up from $44.1 million in 1998. Revenue for the fourth quarter, however, was only $11.7 million, compared with $13.3 million for the fourth quarter of the previous year. For the fourth quarter of 1999 the company reported a net loss of $1 million, compared to a net gain of $2.6 million in the fourth quarter of 1998.
The Rancho Cordova, CA-based company made significant gains through direct sales in the companys two largest markets, the U.S. and Germany, said president and CEO Reinhard J. Warnking.
In the last half of the year, EndoSonics sales declined sharplysomething analysts did not predict. For example, disappointing European sales contributed to lower than expected financial results in the third quarter of 1999. Because EndoSonics European distributor, Jomed International, did not sell products as briskly as had been anticipated, the company reported it would cancel one of two distribution agreements with Jomed (SCAN 10/13/99). This week EndoSonics announced that Jomed will continue acting as its distributor in smaller European markets, while other distributors will handle the business in Japan and some larger markets.
The company has entered into an alliance with North American Scientific, a leading developer of brachytherapy products, to develop the radiation source for EndoSonics intravascular ultrasound-guided radiation catheter (SCAN 1/19/00). EndoSonics hopes to file an application with the FDA for this device in the first half of this year.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.